ANAPLASTIC ASTROCYTOMA
Clinical trials for ANAPLASTIC ASTROCYTOMA explained in plain language.
Never miss a new study
Get alerted when new ANAPLASTIC ASTROCYTOMA trials appear
Sign up with your email to follow new studies for ANAPLASTIC ASTROCYTOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Tracking Kids' health years after brain tumor treatment
Disease control OngoingThis study follows children and teens who are already taking the medications dabrafenib and/or trametinib for various types of brain tumors. The main goal is to monitor their long-term health, safety, and development while they continue treatment. Researchers will track side effe…
Matched conditions: ANAPLASTIC ASTROCYTOMA
Phase: PHASE4 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
New vaccine trial aims to train Kids' immune systems to fight deadly brain cancers
Disease control OngoingThis study is testing a cancer vaccine called SurVaxM in children and young adults with aggressive brain tumors that have come back or progressed. The vaccine is designed to teach the body's immune system to find and destroy cancer cells that carry a specific protein called survi…
Matched conditions: ANAPLASTIC ASTROCYTOMA
Phase: PHASE1 • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
Targeted drug duo aims to control aggressive pediatric brain cancer
Disease control OngoingThis study is testing whether adding two targeted drugs, dabrafenib and trametinib, after standard radiation therapy works better for children and young adults with a specific type of aggressive brain tumor. The treatment is for patients whose tumors have a particular genetic cha…
Matched conditions: ANAPLASTIC ASTROCYTOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
New drug combo tested in fight against aggressive childhood brain cancers
Disease control OngoingThis study is testing whether adding a new drug called veliparib to the standard treatment of radiation and chemotherapy can better control aggressive brain tumors in children and young adults. The trial is for patients aged 3-25 with newly diagnosed high-grade gliomas who have s…
Matched conditions: ANAPLASTIC ASTROCYTOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 04, 2026 15:29 UTC
-
Massive brain cancer study aims to map the best path forward after recurrence
Knowledge-focused OngoingThis study aims to understand which treatment sequences work best for patients whose aggressive brain tumors have returned. Researchers will analyze the medical records of about 1,000 patients to see how different chemotherapy and targeted drug combinations affect survival and ti…
Matched conditions: ANAPLASTIC ASTROCYTOMA
Sponsor: Blokhin's Russian Cancer Research Center • Aim: Knowledge-focused
Last updated Mar 20, 2026 14:48 UTC